FDA Grants Fast Track Designations to 2 Combination Influenza and COVID-19 Vaccine Candidates

Retrieved on: 2024-12-11 21:28:36

Tags for this article:

Influenza vaccine

Vaccine

COVID-19 vaccine

Novavax

H5N1 vaccine clinical trials

Novavax COVID-19 vaccine

Click the tags to see associated articles and topics

FDA Grants Fast Track Designations to 2 Combination Influenza and COVID-19 Vaccine Candidates. View article details on hiswai:

Excerpt

... COVID-19 vaccine NVXC19 (Novavax, Inc.). The second combination candidate consists of the RIV3 influenza vaccine (Flublok; Sanofi) combined with ...

Article found on: www.pharmacytimes.com

View Original Article